#Japan #Tokyo #NTT Precision #Medical Data #Genovision Dock

NTT Precision Medicine Launches New Service

NTT Precision Medicine, headquartered in Chiyoda, Tokyo, is making significant strides in medical data utilization with the launch of a new service based on a vast dataset derived from health claims, health checkups, and genetic information. This data compilation, one of the largest in Japan, features anonymized data for about 110,000 individuals, indicating a robust step toward enhancing healthcare services and medical research.

Background of the New Service

To effectively analyze the effectiveness of health promotion policies and healthcare services, high-quality medical big data is indispensable. This allows for minimal missing information and enables long-term tracking. However, challenges remain concerning the need for reconsent from individuals when the purpose of use is changed or when data is matched across different organizations, hampering the advancement of big data utilization.

NTT Cohort's Unique Dataset

The new dataset is derived from information maintained by the NTT Health Insurance Society, which has been processed to create anonymized information. This information is supplemented by genetic data obtained through the company’s genetic testing service, Genovision Dock®. By integrating these separate anonymized datasets without identifying individuals, NTT has achieved a distinct and large-scale data repository. This dataset will be pivotal for analyzing healthcare costs and diseases, thereby enabling the development of effective health promotion initiatives and healthcare services.

Service Features

Based on the NTT Cohort's new dataset, the company is poised to offer statistical processing of the anonymized information to research institutions and businesses. The results—comprising statistical data and algorithms—will be made available according to client needs, facilitating improved research capabilities across various fields.

Anticipated Benefits

With access to genetic, health checkup, and claims data from the 110,000-strong cohort, the burdens associated with data collection and management are expected to be significantly reduced. This enhancement is anticipated to foster greater economic viability and efficiency in the research and development processes for institute and corporate entities involved in health promotion.

Future Prospects

NTT Precision Medicine aims to leverage data analysis within the NTT Group to not only promote the health of its employees and NTT Health Insurance Society members but to also provide various statistical data and algorithms tailored to specific demands. The company is committed to contributing to medical advancements and improving overall public health through knowledgeable use of this unique dataset.

Additional Information

For clients interested in pursuing further research, the NTT Cohort's service model allows for reconnection with Genovision members, enabling the procurement of additional genetic information, health checkup results, and follow-up survey data after reconsent. There are also options for additional testing or face-to-face consultations as part of field monitoring efforts.